We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Hypofractionated Radiation Acceptable for Localized Prostate Cancer

By MedImaging International staff writers
Posted on 05 Nov 2018
Print article
A new study supports the use of shortened courses of radiation therapy (RT) for early-stage prostate cancer (PC).

Researchers at the University of Ottawa (Canada), Cedars-Sinai Medical Center (Los Angeles, CA, USA), Vanderbilt University Medical Center (VUMC; Nashville, TN, USA), and other institutions participating in a new task force convened by the American Society for Radiation Oncology (ASTRO) conducted a systematic literature review to address key questions and develop an evidence-based guideline for dose-fractionation RT for early-stage PC.

Among the issues discussed were technical aspects, including normal tissue dose constraints, treatment volumes, and use of image guided RT (IMRT) and intensity modulated RT (IMRT). Based on high-quality evidence, a strong consensus was reached to offer moderate hypofractionation across risk groups to patients choosing external beam RT (EBRT), and recommended ultrahypofractionated RT for low- and intermediate-risk PC. For high-risk patients, the routine use of ultrahypofractionated EBRT was not recommended. The study was published on October 11, 2018, in Practical Radiation Oncology.

“These recommendations are intended to provide guidance on moderate hypofractionation and ultrahypofractionation for localized prostate cancer. Men who opt to receive hypofractionated radiation therapy will be able to receive a shorter course of treatment,” concluded lead author Scott Morgan, MD, of the University of Ottawa, and colleagues. “The limits in the current evidentiary base, especially for ultrahypofractionation, highlight the imperative to support large-scale randomized clinical trials and underscore the importance of shared decision making between clinicians and patients.”

RT fractionation is defined as a fraction size of 180 to 200 cGy. Hypofractionation is subdivided into moderate hypofractionation (240-340 cGy) and ultrahypofractionation (a fraction size higher 500 cGy). These pragmatic definitions reflect two distinct approaches to hypofractionation that have emerged in clinical practice. The fraction size gap created (i.e., the gap from 340 cGy and 500 cGy) represents a little-studied range.

Related Links:
University of Ottawa
Cedars-Sinai Medical Center
Vanderbilt University Medical Center


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray Detector
FDR-D-EVO III
Oncology Information System
RayCare
MRI System
uMR 588

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.